Older Americans are losing billions of dollars annually to financial exploitation. Banks and investment firms are training employees to spot red flags and stop the transactions.
Category: Dementia
-
Banks Are Becoming Bulwarks for Vulnerable Seniors
The New York Times – Business: -
Black Former N.F.L. Players May Benefit from New Concussion Deal
A judge approved a race-neutral plan which will force the administrator of the N.F.L. concussions settlement to rescore dementia tests taken by several thousand Black former players who had submitted claims.
-
How to Prevent Aging Parents and Relatives from Making Financial Mistakes
Getting family members to listen to you when you think they are headed down a dangerous financial path can be difficult. But there are preventive steps you can take.
-
Shingles Vaccine Can Decrease Risk of Dementia, Study Finds
A growing body of research suggests that preventing the viral infection can help stave off cognitive decline.
-
Dementia Cases in the U.S. Will Surge in the Coming Decades, Researchers Say
By 2060, new dementia cases per year could double to one million because of the growing population of older Americans, a study predicts.
-
Their Parents Are Giving Money to Scammers. They Can’t Stop Them.
One son couldn’t prevent his father from giving about $1 million in savings to con artists, including one posing as a female wrestling star. The two became estranged.
-
Officials Cast Doubt on a Dementia Drug, but Human Trials Continue
The S.E.C. alleged shortcomings in research said to support the drug, and its developer agreed to a $40 million settlement. Some experts wonder why clinical trials have not been stopped.
-
A Blood Test Accurately Diagnosed Alzheimer’s 90% of the Time, Study Finds
It was much more accurate than primary care doctors using cognitive tests and CT scans. The findings could speed the quest for an affordable and accessible way to diagnose patients with memory problems.
-
New Drug Approved for Early Alzheimer’s
The drug, Kisunla, made by Eli Lilly, is the latest in a new class of treatments that could modestly slow cognitive decline in initial stages of the disease but also carry safety risks.
-
Alzheimer’s Takes a Financial Toll Long Before Diagnosis, Study Finds
New research shows that people who develop dementia often begin falling behind on bills years earlier.
-
Study Suggests Genetics as a Cause, Not Just a Risk, for Some Alzheimers
People with two copies of the gene variant APOE4 are almost certain to get Alzheimer’s, say researchers, who proposed a framework under which such patients could be diagnosed years before symptoms.
-
Apparently Healthy, but Diagnosed With Alzheimer’s?
New criteria could lead to a dementia diagnosis on the basis of a simple blood test, even in the absence of obvious symptoms.